Ekachai Medical Care PCL (BKK:EKH)
Thailand · Delayed Price · Currency is THB 5.15
+0.05 (0.98%)
Apr 30, 2026, 4:36 PM ICT
Ekachai Medical Care PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,240 | 1,307 | 1,209 | 1,049 | 1,146 |
| 1,240 | 1,307 | 1,209 | 1,049 | 1,146 | |
Revenue Growth (YoY) | -5.15% | 8.13% | 15.27% | -8.54% | 77.52% |
Cost of Revenue | 721.92 | 718.76 | 669.22 | 609 | 602.79 |
Gross Profit | 517.7 | 588.13 | 539.39 | 439.51 | 543.57 |
Selling, General & Admin | 220.77 | 281.17 | 223.9 | 197.33 | 173.05 |
Operating Expenses | 220.77 | 281.17 | 223.9 | 197.33 | 173.05 |
Operating Income | 296.94 | 306.95 | 315.49 | 242.18 | 370.52 |
Interest Expense | -1.68 | -1.91 | -1.65 | -1.62 | -1.81 |
Interest & Investment Income | 24.26 | 35.62 | 26.24 | 17.68 | 1.37 |
Earnings From Equity Investments | 0 | -1.21 | -0.07 | - | - |
Other Non Operating Income (Expenses) | 18.32 | 14.09 | 13.29 | 17.55 | 10.29 |
EBT Excluding Unusual Items | 337.84 | 353.54 | 353.3 | 275.79 | 380.37 |
Gain (Loss) on Sale of Investments | - | - | 19.5 | 409.96 | 44.38 |
Pretax Income | 337.84 | 353.54 | 372.8 | 685.75 | 424.76 |
Income Tax Expense | 66.4 | 63.21 | 70.58 | 134.86 | 84.25 |
Earnings From Continuing Operations | 271.44 | 290.34 | 302.22 | 550.89 | 340.51 |
Minority Interest in Earnings | -9.14 | -10.28 | -4.96 | 0.44 | 4.32 |
Net Income | 262.3 | 280.06 | 297.26 | 551.32 | 344.83 |
Net Income to Common | 262.3 | 280.06 | 297.26 | 551.32 | 344.83 |
Net Income Growth | -6.34% | -5.79% | -46.08% | 59.88% | 378.24% |
Shares Outstanding (Basic) | 816 | 767 | 715 | 677 | 653 |
Shares Outstanding (Diluted) | 816 | 767 | 752 | 710 | 657 |
Shares Change (YoY) | 6.39% | 2.04% | 5.83% | 8.22% | 0.40% |
EPS (Basic) | 0.32 | 0.37 | 0.42 | 0.81 | 0.53 |
EPS (Diluted) | 0.32 | 0.36 | 0.40 | 0.78 | 0.53 |
EPS Growth | -11.95% | -7.66% | -49.06% | 47.75% | 376.28% |
Free Cash Flow | -73.69 | 62.61 | 280.81 | 235.31 | 289.36 |
Free Cash Flow Per Share | -0.09 | 0.08 | 0.37 | 0.33 | 0.44 |
Dividend Per Share | 0.300 | 0.550 | 0.293 | 0.305 | 0.229 |
Dividend Growth | -45.45% | 87.91% | -3.91% | 33.13% | 127.21% |
Gross Margin | 41.76% | 45.00% | 44.63% | 41.92% | 47.42% |
Operating Margin | 23.95% | 23.49% | 26.10% | 23.10% | 32.32% |
Profit Margin | 21.16% | 21.43% | 24.59% | 52.58% | 30.08% |
Free Cash Flow Margin | -5.95% | 4.79% | 23.23% | 22.44% | 25.24% |
EBITDA | 371.5 | 386.08 | 394.01 | 311.92 | 438.54 |
EBITDA Margin | 29.97% | 29.54% | 32.60% | 29.75% | 38.26% |
D&A For EBITDA | 74.56 | 79.13 | 78.52 | 69.74 | 68.03 |
EBIT | 296.94 | 306.95 | 315.49 | 242.18 | 370.52 |
EBIT Margin | 23.95% | 23.49% | 26.10% | 23.10% | 32.32% |
Effective Tax Rate | 19.65% | 17.88% | 18.93% | 19.67% | 19.83% |
Revenue as Reported | 1,258 | 1,329 | 1,258 | 1,491 | 1,201 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.